Dr. Kamal Patel, MD

Dr. Patel practices at Central Arkansas Radiation Therapy Institute Inc in North Little Rock, Arkansas.

Dr. Patel's NPI, 1598747164, was assigned on November 18, 2005. Dr. Patel holds Arkansas license E-1015.

Dr. Patel's primary practice is Central Arkansas Radiation Therapy Institute Inc, at 3400 Springhill Dr, North Little Rock, AR 72117 in Pulaski County. The practice phone is (501) 906-3000.

Dr. Patel's primary practice is Central Arkansas Radiation Therapy Institute Inc in North Little Rock, Arkansas. Dr. Patel is also affiliated with Baptist Health Medical Center-North Little Rock. The medical group on file is CARTI. Dmand AI also links Dr. Patel to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Patel practices, 5 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Patel's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Patel is licensed in Arkansas.

CMS data shows 355,471 Medicare services from Dr. Patel across 109 procedure codes in 2024, for 1,470 Medicare patients. Medicare paid $5,838,621 for them.

CMS counts 1,470 Medicare patients who saw Dr. Patel in 2024. The largest group is 65 to 74, with 607 patients. 75% of them have high blood pressure, and 74% have high cholesterol. 10% are also on Medicaid. Their average risk score is 2.03, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Patel's median patient age at 69, with 58% women.

In 2024, Dr. Patel wrote 4,364 Medicare Part D claims for 413 patients. 53% of them were for generic drugs. CMS names the drug for 4,020 of them, across 80 drugs with 11 or more claims each, at $13,924,913 in total drug cost. In 2023, CMS named 2,723 claims across 64 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Patel for performance year 2024, reported as part of a group. Dr. Patel accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 49 papers to Dr. Patel, published from 2013 to 2025. 2022 was the busiest year, with 5. The most frequent topics are COVID-19, Inflammatory Bowel Diseases and SARS-CoV-2. Dr. Patel has published most often in Gut. Dr. Patel's most frequent co-authors are Tariq Ahmad, MD, Sreedhar Subramanian, MD and Jeremy Drew Sanderson, MD.

CMS Open Payments shows 270 general payments to Dr. Patel from 39 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 54% of the total. Pfizer Inc. paid the most, $2,947. It also lists 10 research payments totaling $16,610 from 2021 to 2024.